Nature Communications (Aug 2021)
Activation pathway of a G protein-coupled receptor uncovers conformational intermediates as targets for allosteric drug design
Abstract
G protein-coupled receptors (GPCRs) are a critical target in modern drug development across a wide range of indications. Here the authors provide a comprehensive characterization of a typical GPCR, the angiotensin II (AngII) type 1 receptor (AT1R), and provide insight into its activation mechanism that suggest avenues for the design of allosteric GPCR modulators.